Solid state chemistry

Wilmington PharmaTech provides solid state chemistry services to support the selection, characterization, and control of API physical forms. These services are critical to ensuring optimal stability, bioavailability, and manufacturability of drug substances.

Capabilities include polymorph screening, salt and co-crystal selection, and crystallization process development. The team conducts comprehensive solid form characterization using advanced analytical techniques to assess properties such as crystallinity, hygroscopicity, and thermal behavior.

Process development focuses on identifying robust, scalable crystallization conditions that deliver consistent product quality. Integration with analytical and API development teams ensures seamless transition into manufacturing and regulatory readiness. This approach minimizes risk, supports intellectual property strategies, and enables reliable production of high-quality drug substances.